118 related articles for article (PubMed ID: 227814)
21. Phenotypic mixing of vesicular stomatitis virus and D-type oncornavirus.
Altstein AD; Zhdanov VM; Omelchenko TN; Dzagurov SG; Miller GG; Zavada J
Int J Cancer; 1976 Jun; 17(6):780-4. PubMed ID: 181332
[TBL] [Abstract][Full Text] [Related]
22. Oral vesicular lesions in horses without evidence of vesicular stomatitis virus infection.
Kim L; Morley PS; McCluskey BJ; Mumford EL; Swenson SL; Salman MD
J Am Vet Med Assoc; 2000 May; 216(9):1399-404. PubMed ID: 10800509
[TBL] [Abstract][Full Text] [Related]
23. Neutralization of pseudotypes of vesicular stomatitis virus by sera from avian retrovirus-infected hosts.
Mandeville R; Rohan P; Wainberg MA
Int J Cancer; 1979 Mar; 23(3):415-23. PubMed ID: 220198
[TBL] [Abstract][Full Text] [Related]
24. Recombinant vesicular stomatitis (Indiana) virus expressing New Jersey and Indiana glycoproteins induces neutralizing antibodies to each serotype in swine, a natural host.
Martinez I; Barrera JC; Rodriguez LL; Wertz GW
Vaccine; 2004 Sep; 22(29-30):4035-43. PubMed ID: 15364454
[TBL] [Abstract][Full Text] [Related]
25. Construction and immunogenicity of recombinant pseudotype baculovirus expressing the capsid protein of porcine circovirus type 2 in mice.
Fan H; Pan Y; Fang L; Wang D; Wang S; Jiang Y; Chen H; Xiao S
J Virol Methods; 2008 Jun; 150(1-2):21-6. PubMed ID: 18394722
[TBL] [Abstract][Full Text] [Related]
26. [Formation of pseudotypes of VSV after culture in a human melanoma].
Van Tieghem N; Vercammen-Grandjean A; Liteanu D; Lejeune FJ
Ann Microbiol (Paris); 1978; 129(2):217-26. PubMed ID: 209712
[TBL] [Abstract][Full Text] [Related]
27. Cross-neutralization between vesicular stomatitis virus type Indiana and Chandipura virus.
Dragúnová J; Závada J
Acta Virol; 1979 Jul; 23(4):319-28. PubMed ID: 40419
[TBL] [Abstract][Full Text] [Related]
28. An enzyme-linked immunosorbent assay for the detection of bovine antibodies to vesicular stomatitis virus.
Workman T; Shen D; Woodard L; Yilma T
Am J Vet Res; 1986 Jul; 47(7):1507-12. PubMed ID: 3017162
[TBL] [Abstract][Full Text] [Related]
29. Quantification of Lyssavirus-Neutralizing Antibodies Using Vesicular Stomatitis Virus Pseudotype Particles.
Moeschler S; Locher S; Conzelmann KK; Krämer B; Zimmer G
Viruses; 2016 Sep; 8(9):. PubMed ID: 27649230
[TBL] [Abstract][Full Text] [Related]
30. Influence of N-linked glycans on intracellular transport of hepatitis C virus E1 chimeric glycoprotein and its role in pseudotype virus infectivity.
Beyene A; Basu A; Meyer K; Ray R
Virology; 2004 Jul; 324(2):273-85. PubMed ID: 15207615
[TBL] [Abstract][Full Text] [Related]
31. Vesicular stomatitis virus pseudotypes produced by cells abortively infected or transformed by human cytomegalovirus.
Gönczöl E; Boldogh I; Váczi L
Arch Virol; 1980; 66(3):255-60. PubMed ID: 6255898
[TBL] [Abstract][Full Text] [Related]
32. Anti-complement immunofluorescence test for antibodies to human cytomegalovirus.
Kettering JD; Schmidt NJ; Gallo D; Lennette EH
J Clin Microbiol; 1977 Dec; 6(6):627-32. PubMed ID: 201664
[TBL] [Abstract][Full Text] [Related]
33. Antibody-independent neutralization of vesicular stomatitis virus by human complement. I. Complement requirements.
Mills BJ; Cooper NR
J Immunol; 1978 Oct; 121(4):1549-57. PubMed ID: 212482
[No Abstract] [Full Text] [Related]
34. Monoclonal and polyclonal antibody studies of VSV(hrMMTV) pseudotypes.
Chan JC; East JL; Bowen JM; Massey R; Schochetman G
Virology; 1982 Jul; 120(1):54-64. PubMed ID: 6179293
[No Abstract] [Full Text] [Related]
35. [Serological relation of the VSV/Alagoas virus with other components of the vesicular stomatitis group].
Nozawa CM; Andrade CM
An Microbiol (Rio J); 1978; 23():11-7. PubMed ID: 233607
[No Abstract] [Full Text] [Related]
36. Adaptability costs in immune escape variants of vesicular stomatitis virus.
Novella IS; Gilbertson DL; Borrego B; Domingo E; Holland JJ
Virus Res; 2005 Jan; 107(1):27-34. PubMed ID: 15567030
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of an enzyme-linked immunosorbent assay for detection of antibodies to vesicular stomatitis virus in cattle in an enzootic region of Mexico.
Hernández De Anda J; Salman MD; Webb PA; Keefe TJ; Arregín Arévalo A; Mason J
Am J Vet Res; 1992 Apr; 53(4):440-3. PubMed ID: 1316723
[TBL] [Abstract][Full Text] [Related]
38. Vesicular stomatitis virus can establish persistent infections in Syrian hamsters.
Fultz PN; Shadduck JA; Kang CY; Streilein JW
J Gen Virol; 1982 Dec; 63(2):493-7. PubMed ID: 6296291
[TBL] [Abstract][Full Text] [Related]
39. [Comparison of a few methods for detecting antibodies to the bovine leukemia virus].
Grinenko NF; Tarasishin LA; Valikhov AF; Zajac V; Al'tshteĭn AD
Vopr Virusol; 1980; (3):281-4. PubMed ID: 6254263
[TBL] [Abstract][Full Text] [Related]
40. The use of vesicular stomatitis (visna virus) pseudotypes to demonstrate visna virus receptors in cells from different species.
Gilden DH; Devlin M; Wroblewska Z
Arch Virol; 1981; 67(2):181-5. PubMed ID: 6260064
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
